Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
10/2013
10/03/2013US20130261288 Method for the production of immunoglobulin single variable domains
10/03/2013US20130261287 Antibody design using anti-lipid antibody crystal structures
10/03/2013US20130260455 Notch binding agents and antagonists and methods of use thereof
10/03/2013US20130260393 Tem-1 diagnostic antibodies
10/03/2013US20130260388 Blood markers for diagnosing epithelium derived cancers and monoclonal antibodies thereof
10/03/2013US20130259883 Class i mhc phosphopeptides for cancer immunotherapy and diagnosis
10/03/2013US20130259881 Fusion polypeptides capable of activating receptors
10/03/2013US20130259880 Amatoxin-Conjugates with Improved Linkers
10/03/2013US20130259878 Antibodies
10/03/2013US20130259876 Anti-HLA-B*27 Antibodies and Uses Thereof
10/03/2013US20130259874 Compositions and methods for diagnosing and treating an inflammation
10/03/2013US20130259872 Anti-ilt7- antibody
10/03/2013US20130259871 Human Monoclonal Antibody with Specificity for Dengue Virus Serotype 1 E Protein and Uses Thereof
10/03/2013US20130259869 Rearranged tt virus molecules for use in diagnosis, prevention and treatment of cancer and autoimmunity
10/03/2013US20130259868 Ang-2 Binding Complexes and Uses Thereof
10/03/2013US20130259866 Antibodies that bind il-4 and/or il-13 and their uses
10/03/2013US20130259865 Fully human antibodies to high molecular weight-melanoma associated antigen and uses thereof
10/03/2013US20130259864 Anti-Cobra Toxin Antibody Fragments and Method of Producing a VHH Library
10/03/2013US20130259860 Humanized Antibodies To LIV-1 And Use Of Same To Treat Cancer
10/03/2013US20130259859 Ang2-binding molecules
10/03/2013US20130259806 Dimeric molecular complexes with free cysteine residues and conjugates thereof
10/03/2013CA2875200A1 Fibrosis suppression by inhibiting integrin alpha8beta1 function
10/02/2013EP2644698A1 Multi-specific antigen-binding molecule having alternative function to function of blood coagulation factor viii
10/02/2013EP2644621A1 Apoptotic anti-IgE antibodies
10/02/2013EP2644613A1 Cell wall polymers of enterococcus faecalis and uses thereof
10/02/2013EP2644205A1 Targeting ABCB5 for cancer therapy
10/02/2013EP2643355A2 Human antibodies to the glucagon receptor
10/02/2013EP2643354A1 Novel homogeneous humanized antiproliferation antibodies
10/02/2013EP2643353A1 Multispecific molecules
10/02/2013EP2643352A2 Antigen binding proteins to oncostatin m (osm)
10/02/2013EP2643351A1 Multispecific antigen binding proteins targeting hgf
10/02/2013EP2643350A2 Nk cell modulating treatments and methods for treatment of hematological malignancies
10/02/2013EP2643015A1 Compositions and methods
10/02/2013EP2642979A1 A pharmaceutical composition
10/02/2013EP2642851A1 In vitro method for determining presence of type ii pyrethroids
10/02/2013EP2261377B1 Method of preventing virus:cell fusion by inhibiting the function of the fusion initiation region in RNA viruses having class I membrane fusogenic envelope proteins
10/02/2013DE112011102639T5 Pharmazeutische Zusammensetzung und Verfahren zur Hemmung der Erzeugung oder zur Verstärkung der Eliminierung von P24-Protein The pharmaceutical composition and method for inhibiting production or amplifying elimination of P24 protein
10/02/2013CN103339253A TOMM34 peptides and vaccines including the same
10/02/2013CN103339151A Polyvalent chimeric OspC vaccinogen and diagnostic antigen
10/02/2013CN103339150A Anti-bradykinin B2 receptor (BKB2R) monoclonal antibody
10/02/2013CN103339149A Modulation of the interaction between SorLA and GDNF-family ligand receptors
10/02/2013CN103339148A Alphabodies specifically binding to cytokines or growth factors and/or cytokine or growth factor receptors
10/02/2013CN103339147A Anti-IL-18 antibodies and their uses
10/02/2013CN103339146A Human anti-TAU antibodies
10/02/2013CN103339145A Carrier immunoglobulins and uses thereof
10/02/2013CN103338786A Compositions and methods for treating amyloid plaque associated symptoms
10/02/2013CN103333864A Monoclonal antibody of toxoplasma gondii resistant MIC3 protein and application monoclonal antibody
10/02/2013CN103333862A Anti-beta-conglycinin monoclonal antibody and application thereof
10/02/2013CN103333860A Cells producing antibody compositions
10/02/2013CN103333299A Glycidyl methacrylate and poly (glycol) methacrylate copolymer microsphere, preparation method and application of copolymer microsphere
10/02/2013CN103333249A PSMA (Prostate Specific Membrane Antigen) monoclonal antibody and applications thereof
10/02/2013CN103333248A CD25 nanometer antibody as well as coding sequence and application thereof
10/02/2013CN103333247A Novel monoclonal antibody of VEGFR2 and preparation and application thereof
10/02/2013CN103333246A Anti-EGFR tumor growth inhibitor, preparation method thereof and applications thereof
10/02/2013CN103333245A Anti-cell-acceptor and anti-tumor-growth drug molecule, preparation method thereof and applications thereof
10/02/2013CN103333244A hZimp10 N-terminal high titer antibody prepared by using GST expression system and applications thereof
10/02/2013CN103333243A Immune protein Akirin2 and gene and application thereof
10/02/2013CN103333242A scFv antibody, encoding gene thereof and application thereof to preparation of preparation for treating or preventing infectious bursal disease
10/02/2013CN103333236A Excellent winter sport athlete angiotensin converting enzyme partial polypeptide polyclonal antibody preparation method
10/02/2013CN103333226A Polypeptide marker SPG04 for nasopharyngeal darcinoma radiosensitivity, and ELISA kit prepared by same
10/02/2013CN103333179A Maytansinoid derivatives, preparation method thereof and applications thereof
10/02/2013CN102221607B Antibody composition and application thereof
10/01/2013US8546546 Anti-Muc 17 antibody
10/01/2013US8546545 Antibody to SOST peptide
10/01/2013US8546544 Antibody specifically binding to c-Met and methods of use
10/01/2013US8546543 Fc variants that extend antibody half-life
10/01/2013US8546542 Anti-sweat antigen monoclonal antibody
10/01/2013US8546541 Compositions and methods for modulating lymphocyte activity
10/01/2013US8546540 Antibody targeting osteoclast-related protein Siglec-15
10/01/2013US8546539 Fc receptor-binding polypeptides with modified effector functions
10/01/2013US8546538 B lymphocyte chemoattractant (CXCL13) specific immunoglobulin for use in treatment and prevention of autoimmune encephalomyelitis
10/01/2013US8546531 Methods and reagents for preparing multifunctional probes
10/01/2013US8546530 Process for the manufacture of persilylated peptides
10/01/2013US8546528 Skin or hair binding peptides
10/01/2013US8546526 Peptide or peptidomimetic compounds containing the Arg-Gly-Asp sequence: new class of diagnostic noninvasive tracers as suitable tools for integrin alpha v beta 3-targeted therapy and imaging; antiproliferation agents; angiogenesis inhibititors; antitumor agents; anticarcinogenic agents; kits
10/01/2013US8546331 Modulation of pathogenic CD14+/CD16+ monocytes
10/01/2013US8546093 Detection method for methicillin resistant staphylococcus aureus
10/01/2013US8546086 Use of neuregulin-β as an indicator and/or target
10/01/2013US8546075 Method of detecting hepatitis C virus
10/01/2013US8546072 Substrate for assaying β-glucan and/or endotoxin and assay method
10/01/2013US8545849 Stable and soluble antibodies
10/01/2013US8545847 Human antibodies to the human glucagon receptor and methods of use thereof
10/01/2013US8545843 Treatment of vasculitis
10/01/2013US8545840 Methods for treating cancer using an immunotoxin
10/01/2013US8545838 Compositions and methods for cancer immunotherapy
10/01/2013CA2563516C Monoclonal antibody sc104 and derivative thereof specifically binding to a sialyltetraosyl carbohydrate as a potential anti-tumor therapeutic agent
10/01/2013CA2558612C Method and antibodies for detecting milk allergens
10/01/2013CA2551008C Anti-cd40 antibody mutants
10/01/2013CA2481515C Anti-her2 antibody variants
10/01/2013CA2479835C An ephrin-b receptor protein involved in carcinoma
10/01/2013CA2436530C Environmentally regulated genes of streptococcus suis
10/01/2013CA2433862C Molecular antigen array presenting amyloid beta
10/01/2013CA2424379C Inhibition of complement c5 activation for the treatment and prevention of delayed xenograft or acute vascular rejection
10/01/2013CA2408038C Nucleic acid molecules encoding plant cell cycle proteins and uses therefor
10/01/2013CA2366520C Anti-bacterial vaccine compositions
10/01/2013CA2353802C New protective antigen of group a streptococci
10/01/2013CA2239448C Blockade of t lymphocyte down-regulation associated with ctla-4 signaling
09/2013
09/28/2013CA2773151A1 Cancer diagnostic kit to monitor the activity of protein kinase ck2, the methods and compositions thereof
09/26/2013WO2013142324A1 Neutralizing antibodies to hiv-1 and their use
09/26/2013WO2013142034A1 Anti-mesothelin chimeric antigen receptors
1 ... 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 ... 1494